Soma Pharmacy Blognews

APP Pharmaceutical continues support of FDA’s USP standards for unfractionated heparin
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ), and the leading supplier of heparin sodium to the U.S. market, announced today its continued support of the US Food & Drug Administration (FDA) and medical community for the October 1, [...]

Caraco closes Asset Purchase Agreement with Forest as part of ANDA patent litigation settlement
Caraco Pharmaceutical Laboratories, Ltd. announced that, as part of the previously announced settlement of the legal proceedings related to lexapro (escitalopram oxalate) tablets, it closed an Asset Purchase Agreement (“APA”) transaction with Forest Laboratories, Inc. (“Forest”) to acquire several products from Forest’s [...]

HSPH’s survey on H1N1 vaccines
In a new survey, Harvard School of Public Health (HSPH) researchers found that just 40% of adults are “absolutely certain” they will get the H1N1 vaccine for themselves, and 51% of parents are “absolutely certain” that they will get the vaccine for their children. The survey examined the reasoning among those [...]

Report on the worldwide market for anti-infectives
Drug resistance is a key public health problem and also a problem for makers of branded antibacterial products, according to the findings of a new report. Traditional antibiotics: quinolones, cephalosporins, and penicillins, have seen their market share erode due to loss of effectiveness, while at the same time they [...]

Publix Pharmacies offers to compound tamiflu into an oral suspension for no additional charge
In response to the shortage of tamiflu in liquid form, all 795 Publix Pharmacies will offer to compound tamiflu into an oral suspension.

Misuse of aspirin might have caused high death rate during 1918-1919 influenza pandemic
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article [...]

New study shows that NovoMix 30 is effective for type 2 diabetes patients who are to start on insulin
Data from a new study presented today at the annual meeting of the European Association for the Study of Diabetes (EASD) shows that type 2 diabetes patients starting insulin treatment with once-daily injection of NovoMix® 30 (biphasic [...]

Bradycardia more likely in patients taking cholinesterase inhibitors
People taking one of several drugs commonly prescribed to treat Alzheimer’s disease are more likely to be hospitalized for a potentially serious condition called bradycardia than patients not taking these medications.

TNF-alpha inhibitor drug class sales to increase up to $1.1 billion in 2018
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to sales of Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe Pharma’s Remicade, the two emerging TNF-alpha inhibitors Abbott/Eisai’s Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe Pharma/Janssen’s Simponi [...]

Chinese government places second purchase order for Sinovac Biotech’s H1N1 vaccine
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that Sinovac has received its second purchase order for its H1N1 vaccine, PANFLU.1, from the Ministry of Industry and Information Technology of the People’s Republic of China for the national stockpiling plan.